Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Phase 1 Cancer Trials

West Valley City, Utah

Phase 1 cancer trials in West Valley City, UT

42 Phase 1 cancer studies are recruiting participants at sites in West Valley City as of November 17, 2026, according to ClinicalTrials.gov. Phase 1 Cancer Trials can help you understand your options and connect with a study team.

Call (888) 927-9038
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

West Valley City at a glance

Breast cancer studies recruiting in West Valley City

Basic details from each study's public record (the 30 most recently updated of 42). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. A Phase 1/2 Study of IAM1363 in HER2 Cancers

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Iambic Therapeutics, Inc
    Study site
    START Mountain Region
    Registry record
    NCT06253871 · updated
  2. A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Astellas Pharma Global Development, Inc.
    Study site
    START Mountain Region
    Registry record
    NCT07488676 · updated
  3. A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Pliant Therapeutics, Inc.
    Study site
    START Mountain Region
    Registry record
    NCT06270706 · updated
  4. A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Stemline Therapeutics, Inc.
    Study site
    START Mountain
    Registry record
    NCT06638307 · updated
  5. A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    IDEAYA Biosciences
    Study site
    START Mountain Region, LLC
    Registry record
    NCT07503808 · updated
  6. A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    NiKang Therapeutics, Inc.
    Study site
    South Texas Accelerated Research Therapeutics (START) Mountain Region
    Registry record
    NCT07029399 · updated
  7. A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Pfizer
    Study site
    START Mountain Region
    Registry record
    NCT07318805 · updated
  8. Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Genmab
    Study site
    START Mountain Region
    Registry record
    NCT05579366 · updated
  9. A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Eli Lilly and Company
    Study site
    START Mountain Region
    Registry record
    NCT06400472 · updated
  10. A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Eli Lilly and Company
    Study site
    START Mountain Region
    Registry record
    NCT06465069 · updated
  11. A Study of MGC026 in Participants With Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    MacroGenics
    Study site
    START Mountain Region
    Registry record
    NCT06242470 · updated
  12. A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Terremoto Biosciences Inc.
    Study site
    START Center for Cancer Research
    Registry record
    NCT07109726 · updated
  13. A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Cogent Biosciences, Inc.
    Study site
    START Mountain Region, LLC
    Registry record
    NCT07383506 · updated
  14. A Study to Evaluate ATX-898 in Participants With Advanced Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Antares Therapeutics, Inc
    Study site
    START Mountain Region Cancer Center
    Registry record
    NCT07767474 · updated
  15. Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Olema Oncology, Inc.
    Study site
    START - Mountain Region
    Registry record
    NCT06784193 · updated
  16. A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Cogent Biosciences, Inc.
    Study site
    START Mountain Region
    Registry record
    NCT07361562 · updated
  17. Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.
    Study site
    START Mountain Region
    Registry record
    NCT05985655 · updated
  18. A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Seagen, a wholly owned subsidiary of Pfizer
    Study site
    START Mountain Region
    Registry record
    NCT05208762 · updated

Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in West Valley City, UT on ClinicalTrials.gov.

Lung cancer studies recruiting in West Valley City

  1. A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    IDEAYA Biosciences
    Study site
    START Mountain Region, LLC
    Registry record
    NCT07277413 · updated
  2. A Phase 1/2 Study of TRI-611 in ALK-Positive NSCLC

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    TRIANA Biomedicines, Inc.
    Study site
    START-Mountain Region
    Registry record
    NCT07491497 · updated
  3. Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Sairopa B.V.
    Study site
    Start Center for Cancer Research - Mountain Region
    Registry record
    NCT05856981 · updated
  4. FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Gilead Sciences
    Study site
    START Mountain Region
    Registry record
    NCT06303505 · updated
  5. AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

    • Phase 1/2
    • Ages 18 to 75
    • All sexes
    Sponsor
    Avenzo Therapeutics, Inc.
    Study site
    Avenzo Therapeutics Recruiting Site
    Registry record
    NCT07038343 · updated
  6. A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    BioNTech SE
    Study site
    START Mountain Region
    Registry record
    NCT07070232 · updated
  7. A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    ALX Oncology Inc.
    Study site
    ALX Center 4
    Registry record
    NCT07085091 · updated
  8. A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Seagen, a wholly owned subsidiary of Pfizer
    Study site
    South Texas Accelerated Research Therapeutics Mountain Region
    Registry record
    NCT06131840 · updated

Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in West Valley City, UT on ClinicalTrials.gov.

Prostate cancer studies recruiting in West Valley City

  1. First-Time-in-Human Study of GSK5471713 in Adults With mCRPC

    • Phase 1/2
    • Ages 18 and older
    • Male participants
    Sponsor
    GlaxoSmithKline
    Study site
    GSK Investigational Site
    Registry record
    NCT07332455 · updated
  2. A Study of JNJ-98768111 in Participants With Advanced Prostate Cancer

    • Phase 1
    • Ages 18 and older
    • Male participants
    Sponsor
    Janssen Research & Development, LLC
    Study site
    START Mountain Region
    Registry record
    NCT07746713 · updated

Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in West Valley City, UT on ClinicalTrials.gov.

Melanoma studies recruiting in West Valley City

  1. A Study of mRNA-4106 or mRNA-4200 Administered Alone or in Combination With Anti-Cancer Agents in Participants With Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    ModernaTX, Inc.
    Study site
    START Mountain Region
    Registry record
    NCT06880549 · updated

Source: ClinicalTrials.gov. Data processed . See every melanoma study recruiting in West Valley City, UT on ClinicalTrials.gov.

Lymphoma studies recruiting in West Valley City

  1. A Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer

    • Phase 1/2
    • Ages 12 and older
    • All sexes
    Sponsor
    Recursion Pharmaceuticals Inc.
    Study site
    START Mountain Region
    Registry record
    NCT06678659 · updated

Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in West Valley City, UT on ClinicalTrials.gov.

Ask about studies near West Valley City

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

More locations in Utah

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.

Phase 1 Cancer Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-9038

or send a short form

How should we reach you?

Call